安拓伏 EnVAX-A71 文獻
2023 - 06 - 05 公開文獻發表
2022
▶ Immunogenicity and Safety for an Inactivated Enterovirus A71 Vaccine in Infants and Young Children: a randomized, double-blind, placebo-controlled Phase III Clinical Trial. (NCT05099029)
2019
▶ Hung MC et al. Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6 years and 2-35 months of age- an open-label, randomized phase IIb clinical trial. Vaccine Volume 37, Issue 37, 3 September 2019, Pages 5559-5566 (NCT03268083)
2015
▶ CY Wu et al. Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse. PLoS ONE Volumn 10, Issune 8, 19 August 2015, e0136420
2013
▶ Chou AH et al. Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult volunteers. PLoS One Volume 8, Issue 11, 21 November 2013, e79783 (NCT01268787)
▶ Cheng A et al. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine Volume 31, Issue 20, 7 May 2013, Pages 2471-2476 (NCT01268787)
